NOX 2.86% 7.2¢ noxopharm limited

News: NOX Noxopharm Announces Results From Novel Dual-Cell Therapy Pancreatic Cancer Study

  1. 191,609 Posts.
    lightbulb Created with Sketch. 2809

    Sept 14 (Reuters) - Noxopharm Ltd (NOX) :

    • ANNOUNCES RESULTS FROM NOVEL 'DUAL-CELL' THERAPY PANCREATIC CANCER STUDY
    • MAJOR FINDINGS WERE THAT CRO-67 KILLED TUMOUR CELLS AS WELL AS BARRIER CELLS IN SAMPLES TAKEN FROM SIX PATIENTS
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
0.002(2.86%)
Mkt cap ! $21.04M
Open High Low Value Volume
7.2¢ 7.2¢ 7.2¢ $1.367K 18.99K

Buyers (Bids)

No. Vol. Price($)
1 72463 6.9¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 8810 1
View Market Depth
Last trade - 15.33pm 26/07/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.